Bacterial Infections Post Liver Transplantation; One Year Experience

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 67

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_TIPS-9-3_005

تاریخ نمایه سازی: 9 آبان 1402

چکیده مقاله:

In adults with acute and chronic end-stage liver disease, liver transplantation (LT) is the only treatment option for these patients. On the other hand, one of the substantial causes of death in these patients is bacterial infection after transplantation, which should be considered as well as appropriate antibacterial treatment. For this reason, this study was designed to provide a multi-faceted review of different types of infections after transplantation and their treatment options during one year of experience in the largest LT center for adult patients in Iran. In this retrospective cohort study, records from all individuals over ۱۸ years of age candidates for liver transplantation in Abu-Ali Sina hospital, Shiraz, Fars, Iran from ۲۰۱۸   March to ۲۰۱۹ March , were assessed. Demographic, laboratory, and clinical data were extracted in addition to the antimicrobial therapy. In this study, ۴۱۲ patients included. ۱۵.۷۷% of patients were infected after transplantation, of which ۶۱.۱۷% of the isolated pathogens were gram-negative and ۳۸.۸۳% were gram-positive. The most common isolated gram-positive and gram-negative microorganisms include staphylococci (۲۷.۶۹%) and Klebsiella (۲۷.۶۹%), respectively. Urinary tract infection was the most common type of infection after transplantation in adult liver transplant recipients, and length of stay in ICU, length of hospital stay, length of mechanical ventilation are among the risk factors affecting bacterial infection after LT.

نویسندگان

Mojtaba Shafiekhani

Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

Afsaneh Vazin

Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

Hamed Nikoupor

Shiraz Transplant Center, Abu-Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Firoozifar

Shiraz Transplant Center, Abu-Ali Sina Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

Mahyar Shekoohi

Department of Pharmacognosy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence ...
  • Mallik M, Singhai A, Khadanga S, Ingle V. The Significant ...
  • Babb RR. Chronic liver disease. The scope of causes and ...
  • Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. ...
  • O'Grady J. Timing and benefit of liver transplantation in acute ...
  • Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant ...
  • Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. ...
  • Hernandez Mdel P, Martin P, Simkins J. Infectious Complications After ...
  • van Hoek B, de Rooij BJ, Verspaget HW. Risk factors ...
  • Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after ...
  • Kamath PS, Kim WR; Advanced Liver Disease Study Group. The ...
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical ...
  • Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of ...
  • Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, ...
  • Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, ...
  • Li C, Wen TF, Mi K, Wang C, Yan LN, ...
  • Jafarpour Z, Pouladfar G, Malek Hosseini SA, Firoozifar M, Jafari ...
  • Righi E. Management of bacterial and fungal infections in end ...
  • Sun HY, Cacciarelli TV, Singh N. Identifying a targeted population ...
  • Razonable RR, Findlay JY, O'Riordan A, Burroughs SG, Ghobrial RM, ...
  • Freire MP, Oshiro IC, Pierrotti LC, Bonazzi PR, de Oliveira ...
  • Otan E, Aydin C, Usta S, Kutluturk K, Kayaalp C, ...
  • So M, Walti L. Challenges of Antimicrobial Resistance and Stewardship ...
  • Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, ...
  • Sganga G, Bianco G, Fiori B, Nure E, Spanu T, ...
  • Liu T, Zhang Y, Wan Q. Methicillin-resistant Staphylococcus aureus bacteremia ...
  • Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, ...
  • Takatsuki M, Eguchi S, Yamanouchi K, Hidaka M, Soyama A, ...
  • Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. ...
  • Garzoni C, Vergidis P; AST Infectious Diseases Community of Practice. ...
  • Nellore A, Huprikar S; AST ID Community of Practice. Vancomycin-resistant ...
  • Shafiekhani M, Shabani-Borujeni M, Karimian A, MomeniTabar MJ, Zare Z, ...
  • نمایش کامل مراجع